AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2014
Dec 15, 2014
35066_dirs_2014-12-15_ffa51eac-32da-42db-9baf-74ee48619198.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2014-12-11
Reporting Person: Meckler Jeffrey A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-11 | Common Stock | P | 25000 | $0.45 | Acquired | 25000 | Direct |
| 2014-12-11 | Common Stock | P | 25000 | $0.4544 | Acquired | 50000 | Direct |
| 2014-12-11 | Common Stock | P | 50000 | $0.46 | Acquired | 100000 | Direct |
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15